Upgrade to SI Premium - Free Trial

Abbott Labs (ABT) PT Lowered to $130 at RBC Capital

April 17, 2026 9:22 AM
RBC Capital analyst Shagun Singh lowered the price target on Abbott Labs (NYSE: ABT) to $130.00 (from $135.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change